Ptc Therapeutics Inc (PTCT) financials

NASDAQ · Health Care

$59.97 -6.97% Close Oct 30, 2026 Live

Ptc Therapeutics revenue and earnings by year

Ptc Therapeutics's revenue was $1.73 billion in the fiscal year to December 31, 2025, up 114.5% from the year before. Net income was $683 million, 39.4% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 40.2% a year on average.

RevenueNet income
$0$1.00B
2016201720182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In billions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenue1.730.810.940.700.540.380.310.260.190.08
Revenue growth114.5%-14.0%34.2%29.7%41.4%24.0%16.0%36.2%135.0%—
Gross profit1.680.750.870.650.510.360.290.250.19—
Gross margin97.3%92.9%93.0%93.6%94.0%95.0%96.0%95.2%97.6%—
Operating income0.87-0.31-0.57-0.47-0.37-0.41-0.19-0.10-0.06-0.13
Operating margin50.0%-38.1%-60.5%-67.7%-69.6%-107.3%-62.8%-36.4%-33.1%-159.7%
Net income0.68-0.36-0.63-0.56-0.52-0.44-0.25-0.13-0.08-0.14
Net margin39.4%-45.0%-66.8%-80.0%-97.3%-115.1%-82.0%-48.4%-40.6%-171.8%
Diluted EPS$7.78-$4.73-$8.37-$7.79-$7.43—————
Free cash flow0.70-0.28-0.19-0.39-0.28-0.21-0.11-0.03-0.01-0.11

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open PTCT in Markets.

See also: PTCT returns

No forecast, no recommendation. This page describes Ptc Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.